Sarissa Capital Management as of Dec. 31, 2014
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 16 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 31.2 | $88M | 13M | 6.87 | |
| Quest Diagnostics Incorporated (DGX) | 18.4 | $52M | 775k | 67.06 | |
| Amgen (AMGN) | 17.9 | $51M | 318k | 159.29 | |
| Merck & Co (MRK) | 8.0 | $23M | 400k | 56.79 | |
| Agilent Technologies Inc C ommon (A) | 6.7 | $19M | 460k | 40.94 | |
| Bio-reference Labs Com $.01 New | 4.4 | $13M | 390k | 32.13 | |
| Repros Therapeutics Com New | 4.0 | $11M | 1.1M | 9.97 | |
| Vivus | 2.6 | $7.4M | 2.6M | 2.88 | |
| Intra Cellular Therapies (ITCI) | 2.2 | $6.4M | 360k | 17.65 | |
| Kindred Biosciences | 1.8 | $5.1M | 689k | 7.45 | |
| AVEO Pharmaceuticals | 0.8 | $2.2M | 2.6M | 0.84 | |
| Biosante Pharmaceuticals (ANIP) | 0.6 | $1.7M | 31k | 56.39 | |
| Targacept | 0.6 | $1.7M | 630k | 2.63 | |
| Apricus Bioscience | 0.4 | $1.0M | 1.0M | 1.00 | |
| Eleven Biotherapeutics | 0.2 | $489k | 41k | 11.87 | |
| Cyclacel Pharmaceuticals Com New | 0.1 | $263k | 376k | 0.70 |
